1256
I. Wandzik et al.
g, 22%) as the second fraction (RF: 0.17). Analytical data for 15 are in accordance with Johnson and
Widlanski.[4]
11. Felix, A.M.; Heimer, E.P.; Lambros, T.J.; Tzougraki, C.; Meienhofer, J. Rapid Removal of Protecting
Groups from Peptides by Catalytic Transfer Hydrogenation with 1,4-Cyclohexadiene. J. Org. Chem.
1978, 43, 4194–4196.
12. Procedure for final O-Cbz, N-Cbz and O-Bn deprotection (Scheme 1, procedure d): To a solution of
8 (109 mg, 0.10 mmol) in MeOH (10 mL) 1,4-cyclohexadiene (0.6 mL) and Pearlman’s catalyst
(75 mg) were added. Reaction mixture was stirred at room temperature overnight. After re-
moval of the catalyst by filtration crude product were purified by column chromatography with
CHCl3/MeOH 10:1 → 5:1 (v/v) solvent system to yield 3 (35 mg, 90%) as a white solid. Compound
3 was prepared using protected uridine 14 and glucal 4 according to previously described
procedure.[1]
13. Analytical data for new compounds: 5ꢁ-O-(2-deoxy-a-D-glucopyranosyl)uridine, 3: solid; [α]D20+36.0
(MeOH, c 1.0); 1H NMR (300 MHz, CD3OD): δ 1.70 (ddd, 1H, J 3.5, 11.8, 13.2 Hz, H-2ꢁꢁax), 2.09
(ddd, 1H, J 1.1, 5.0, 13.2 Hz, H-2ꢁꢁeq), 3.26 (t, 1H, J 9.0 Hz, H-4ꢁꢁ), 3.53 (ddd, 1H, J 2.3, 5.6, 9.0 Hz,
H-5ꢁ), 3.67–3.74 (m, 2H, H-6ꢁꢁa,b), 3.79 (ddd, J 5.0, 9.0, 11.8 Hz, H-3ꢁꢁ), 3.83 (dd, 1H, J 2.3, 11.5
Hz, H-5ꢁa), 3.94 (dd, 1H, J 2.6, 11.5 Hz, H-5ꢁb), 4.12–4.19 (m, 3H, H-2ꢁ, 3ꢁ, 4ꢁ), 4.99 (br d, 1H, J
3.2 Hz, H-1ꢁꢁ), 5.80 (d, J 8.2 Hz, H-5), 5.88 (d, 1H, J 4.1 Hz, H-1ꢁ), 7.98 (d, 1H, J 8.2 Hz, H-6); 13
C
NMR: δ 38.86 (C-2ꢁꢁ), 62.87, 67.11, 69.99, 71.32, 73.21, 74.53, 76.12, 84.46 (C-2ꢁ, C-3ꢁ, C-4ꢁ, C-5ꢁ, C-3ꢁꢁ,
C-4ꢁꢁ, C-5ꢁꢁ, C-6ꢁꢁ), 90.91 (C-1ꢁ), 98.84 (C-1ꢁꢁ), 102.60 (C-5), 142.03 (C-6), 152.37 (C-2), 166.19 (C-4);
ESI-HRMS: Calcd for C15H22N2O10Na ([M+Na]+): m/z 413.1167, found: m/z 413.1150. N 3-benzyl-
2ꢁ,3ꢁ-O-isopropylidene-5ꢁ-(2-deoxy-α-D-glucopyranosyl)uridine, 7: solid; [α]2D0+27.3 (MeOH, c 0.5);
1H NMR (CDCl3): δ 1.35; 1.54 (2s; 6H; C(CH3)2); 1.61 (ddd, 1H, J 3.7, 12.0, 13.4 Hz; H-2ꢁꢁax),
1.98 (ddd, 1H, J ≈ 0, 5.2, 13.4 Hz, H-2ꢁꢁeq), 3.22 (t, 1H, J 9.0 Hz, H-4ꢁꢁ), 3.44–3.91 (m, 6H, H-5ꢁa,b,
H-3ꢁꢁ, H-5ꢁꢁ, H-6ꢁꢁa,b), 4.43 (m, 1H, H-4ꢁ), 4.82–4.86 (m, 2H, H-2ꢁ, H-3ꢁ), 4.91 (d, 1H, J 2.9 Hz, H-1ꢁꢁ),
5.02–5.14 (qAB, 2H, N-CH2Ph), 5.83 (d, 1H, J 8.1 Hz, H-5), 5.86 (d, 1H, J 1.7 Hz, H-1ꢁ), 7.19–7.38
(m, 5H, Ph), 7.79 (d, 1H, J 8.1 Hz, H-6); 13C NMR: d 25.55, 27.57 (C(CH3)2), 38.63 (C-2ꢁꢁ), 45.14
(N-CH2Ph), 62.79 (C−5ꢁ), 68.22, 69.84, 73.13, 74.58 (C-3ꢁꢁ, C-4ꢁꢁ, C-5ꢁꢁ, C-6ꢁꢁ), 82.59, 86.78, 87.29
(C-2ꢁ, C-3ꢁ, C-4ꢁ), 95.47 (C-1ꢁ), 98.87 (C-1ꢁꢁ), 101.77 (C-5), 114.94 (C(CH3)2), 128.55, 129.27, 129.49
(Ph), 138.14 (Phq), 141,50 (C-6), 152.29 (C-2), 164.91 (C-4), ESI-HRMS: Calcd for C25H32N2O10Na
([M+Na]+): m/z 543.1949, found: m/z 543.1968. N 3,2ꢁ,3ꢁ-O-tris-(benzyloxycarbonyl)uridine, 14: oil;
[α]2D0-22.3 (CHCl3, c 3.0); 1H NMR: δ 2.78 (dd, 1H, J 3.6, 5.9 Hz, 5-OH), 3.78 (ddd, 1H, J 1.8,
5.9, 12.1, Hz, H-5ꢁa), 3,89 (m, 1H, H-5ꢁb), 4.25 (m, 1H, H-4ꢁ), 5.04–5.42 (m, 6H, 3CH2Ph), 5.39
(dd, 1H, J 3.5, 5.7 Hz, H-2ꢁ), 5.48 (dd, 1H, J 5.7, 5.7 Hz, H-3ꢁ), 5.76 (d, 1H, J 8.2 Hz, H-5), 5.95
(d, 1H, J 5.7 Hz, H-1ꢁ), 7.25–7.44 (m, 15H, Ph), 7.64 (d, J 8.2 Hz 1H, H-6), 13C NMR: d 61.85
(C-5ꢁ), 70.69, 70.87 (2PhCH2OC(O)O), 71.78 (PhCH2OC(O)N), 74.24, 75.92 (C-2ꢁ, C-3ꢁ), 83.34
(C-4ꢁ), 89.02 (C-1ꢁ), 102.88 (C-5), 128.65–129.20 (Ph), 133.84, 134.70, 134.78 (Phq), 140.68 (C-6),
148.56 (N-C(O)O), 149.89 (C-2), 154.03, 154.36 (2O-C(O)O), 160.30 (C-4); ESI-HRMS: Calcd for
C
33H30N2O12Na ([M+Na]+): m/z 669.1691, found: m/z 669.1687.